This study explores the biogenics hypothesis, suggesting that bioactive compounds from phytoplankton in Sea Spray Aerosol (SSA) may positively affect human health by inhibiting specific signaling pathways. It highlights the complex relationship between SSA exposure, phytoplankton activity, and seasonal variation, offering insights into potential health benefits and emphasizing the need for further investigation of phytoplankton-derived bioactive compounds in human health.